This is consistent with the fact that HMC-1 cells were established from an MCL patients, whereas ROSA cells are normal CD34+ cells from umbilical cord blood ‘engineered’ to express mutant KIT; thus, they do not fully mirror the complexity of advanced disease. The gene discussed is CD34; the disease is mantle cell lymphoma.